X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (850) 850
Publication (74) 74
Book Review (17) 17
Newspaper Article (8) 8
Conference Proceeding (5) 5
Book Chapter (4) 4
Newsletter (4) 4
Dissertation (3) 3
Book / eBook (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (594) 594
cancer (453) 453
humans (435) 435
immunotherapy (394) 394
oncology (394) 394
tumors (379) 379
immunology (314) 314
lymphocytes (304) 304
immune system (234) 234
prognosis (227) 227
immune response (194) 194
female (184) 184
lymphocytes t (173) 173
animals (166) 166
metastasis (164) 164
dendritic cells (163) 163
survival (162) 162
tumor-infiltrating lymphocytes (160) 160
t cells (158) 158
chemotherapy (157) 157
medical prognosis (157) 157
patients (156) 156
tumor microenvironment (154) 154
melanoma (150) 150
male (146) 146
expression (136) 136
cancer therapies (134) 134
metastases (134) 134
immune checkpoint (130) 130
neoplasms - immunology (130) 130
antigens (127) 127
middle aged (123) 123
research (121) 121
analysis (119) 119
gene expression (118) 118
immune contexture (118) 118
regulatory t-cells (117) 117
review (117) 117
cytotoxicity (115) 115
t-cells (115) 115
care and treatment (112) 112
aged (111) 111
biomarkers (111) 111
cd8 antigen (107) 107
colorectal cancer (105) 105
apoptosis (102) 102
inflammation (100) 100
immunohistochemistry (97) 97
lymphocytes, tumor-infiltrating - immunology (96) 96
immune cells (94) 94
cytokines (89) 89
macrophages (89) 89
tumor microenvironment - immunology (89) 89
adult (85) 85
lung cancer (82) 82
health aspects (80) 80
medical research (79) 79
cell biology (78) 78
breast cancer (77) 77
neoplasms - therapy (77) 77
pathology (73) 73
mice (70) 70
immunity (69) 69
medicine, research & experimental (68) 68
development and progression (67) 67
ligands (63) 63
immunotherapy - methods (62) 62
pd-1 blockade (62) 62
aged, 80 and over (61) 61
carcinoma (61) 61
clinical trials (61) 61
cells (59) 59
chemical and pharmacologic phenomena (59) 59
multidisciplinary sciences (59) 59
research article (59) 59
medicine & public health (58) 58
mutation (58) 58
neoplasms - pathology (58) 58
suppressor-cells (58) 58
medicine (57) 57
studies (57) 57
microenvironment (56) 56
neoplasms. tumors. oncology. including cancer and carcinogens (56) 56
cell survival (55) 55
surgery (55) 55
cd8-positive t-lymphocytes - immunology (53) 53
colorectal-cancer (53) 53
infiltration (53) 53
therapy (53) 53
pd-l1 (52) 52
t cell receptors (52) 52
tumor cells (52) 52
cell line, tumor (51) 51
lung-cancer (51) 51
genetic aspects (50) 50
pd-l1 protein (50) 50
survival analysis (49) 49
chemokines (48) 48
lymphocytes, tumor-infiltrating - pathology (48) 48
pd-1 protein (48) 48
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Current Opinion in Gastroenterology, ISSN 0267-1379, 03/2020, Volume 36, Issue 2, pp. 70 - 76
PURPOSE OF REVIEWConsidering the failure of standard treatments (i.e. surgery, radiotherapy, chemotherapy) in treating cholangiocarcinoma (CCA), introduction... 
NEUTROPHIL | CANCER-ASSOCIATED FIBROBLASTS | DENDRITIC CELLS | LYMPHOCYTE | tumor-infiltrating T lymphocytes | tumor-associated neutrophils | MONOCYTES | immune contexture | PROGNOSTIC VALUE | tumor-associated macrophages | MICROENVIRONMENT | IMMUNOTHERAPY | ACTIVATED MACROPHAGES | GASTROENTEROLOGY & HEPATOLOGY | cholangiocarcinoma | Life Sciences | Cancer
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2018, Volume 8, Issue 1, pp. 1 - 11
The general relevance of the immune system for cancer development and therapy is increasingly recognized. However and although the immune contexture of most... 
Liver cancer | Cell survival | Cytotoxicity | Hepatocellular carcinoma | Lymphocytes T | Macrophages | Tumors | Immune system
Journal Article
FRONTIERS IN IMMUNOLOGY, ISSN 1664-3224, 03/2019, Volume 10, p. 603
One in seven men in North America is expected to be diagnosed with prostate cancer (PCa) during their lifetime (1, 2). While a wide range of treatment options... 
DNA damage response | DNA-DAMAGE RESPONSE | PTEN | IMMUNOLOGY | tumor immune microenvironment (TIME) | CASTRATION | MHC CLASS-I | prostate cancer | REPAIR | PREDICTIVE BIOMARKERS | immunotherapy | immune checkpoint | RESISTANCE | hormone therapy | INTERFERONS | EXPRESSION | T-LYMPHOCYTES | Treatment outcome | Usage | Care and treatment | Analysis | Immunotherapy | Clinical trials | Prostate cancer
Journal Article
Journal Article
CANCERS, ISSN 2072-6694, 09/2019, Volume 11, Issue 9, p. 1380
Adolescents and young adults (AYA) with rhabdomyosarcoma (RMS) form a subgroup of patients whose optimal clinical management and access to care remain a... 
YOUNG-ADULTS | adolescents | LANDSCAPE | GENOMIC ANALYSIS | immune contexture | IDENTIFICATION | CANCER | pediatric tumors | MICRORNA-223 | SKELETAL-MUSCLE | ONCOLOGY | GROWTH | miRNA | rhabdomyosarcoma | EXPRESSION | gene expression
Journal Article
Molecular Oncology, ISSN 1574-7891, 12/2016, Volume 10, Issue 10, pp. 1551 - 1558
Checkpoint blockade therapy has emerged as a novel approach for cancer immunotherapy in several malignancies. However, patient prognosis and disease... 
Gastric carcinoma | Immune checkpoint | Prognosis | Tumor-infiltrating lymphocytes | Programmed cell death 1 ligand 1 | MESSENGER-RNA EXPRESSION | LUNG-CANCER | IMPACT | MICROENVIRONMENT | ONCOLOGY | REGULATORY T-CELLS | PD-L1 | AGGRESSIVENESS | CARCINOMA | PROGRAMMED DEATH-1 LIGAND-1 | CLINICAL-SIGNIFICANCE | Immunohistochemistry | Stomach - pathology | Stomach Neoplasms - diagnosis | Stomach Neoplasms - virology | Stomach - immunology | Humans | Middle Aged | Male | Stomach Neoplasms - pathology | Lymphocytes, Tumor-Infiltrating - virology | B7-H1 Antigen - immunology | Stomach Neoplasms - immunology | Herpesvirus 4, Human - isolation & purification | Lymphocytes, Tumor-Infiltrating - pathology | Survival Analysis | Epstein-Barr Virus Infections - complications | Epstein-Barr Virus Infections - diagnosis | Female | B7-H1 Antigen - analysis | Stomach - virology | Lymphocytes, Tumor-Infiltrating - immunology | Medical colleges | RNA | Oncology, Experimental | Development and progression | Research | Biological response modifiers | Stomach cancer | Messenger RNA | Cell death | Immunotherapy | Epstein-Barr virus | Cancer | Interferon gamma | Antigens | Cell survival | Infections | mRNA | Hybridization | Patients | Metastases | Studies | Polymerase chain reaction | Lymphocytes | Medical prognosis | Risk assessment | Interferon | Localization | Gastric cancer | Apoptosis | Tumors
Journal Article
OncoImmunology, ISSN 2162-4011, 12/2016, Volume 5, Issue 12, p. e1255394
There is now growing evidence that the immune contexture influences cancer progression and clinical outcome of patients with non-small cell lung cancer... 
non-small cell lung cancer | neoadjuvant chemotherapy | immune contexture | Histological response | survival | INDUCTION CHEMOTHERAPY | RESECTION | LONG-TERM SURVIVAL | TUMOR | IMMUNOLOGY | CELL CARCINOMA | CHECKPOINT BLOCKADE | IMPACT | ANTI-PD-L1 ANTIBODY | THERAPY | ONCOLOGY | LYMPHOID STRUCTURES
Journal Article
Conference Proceeding